TGR5 Receptor Agonist
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-14229-5MG | 5 mg | 138,00 | Add | |
| HY-14229-1ML | 10mM/1mL | 151,00 | Add | |
| HY-14229-10MG | 10 mg | 222,00 | Add | |
| HY-14229-50MG | 50 mg | 753,00 | Add | |
| HY-14229-100MG | 100 mg | 1'323,00 | Add | |
| HY-14229-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
TGR5 Receptor Agonist (CCDC), a potent Takeda G protein-coupled receptor 5 (TGR5; GPCR19) agonist, shows improved potency in the U2-OS cells and melanophore cells with pEC50s of 6.8 and 7.5, respectively. TGR5 Receptor Agonist can induce peripheral and central hypersensitivity to bladder distension in mice, and increase intracellular Ca2+ concentration. TGR5 Receptor Agonist can also reduces food intake and improves insulin responsiveness, in diet-induced obese mice. TGR5 Receptor Agonist can be used to research diabetes, bladder hypersensitivity and anti-obesity[1][2][3][4].
| Category | Protein |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, GPCR/G Protein,Membrane Transporter/Ion Channel,Neuronal Signaling |
| Format | Solubility: DMSO : ≥ 48 mg/mL |
| Grade | Clinical information: No Development Reported |
| Purity | 99.86% |
| Molecular Formula | C18H14Cl2N2O2 |
| Molecular Weight | 361.22 |
| CAS-Number | 1197300-24-5 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
